WebOct 21, 2024 · Dr. Harry Kleanthous, an skilled within the vaccine discipline, has devoted 30 years to the vaccine business in each biotech & massive biopharma, serving as Vice … WebHarry Kleanthous's 56 research works with 1,135 citations and 6,847 reads, including: Enhanced protective efficacy of a novel, thermostable, RBD-S2 fusion immunogen against SARS-CoV-2 and its variants
SK bioscience Appoints New Executives towards Global Business …
WebSep 26, 2024 · View Harry Kleanthous' email address (h*****@gatesf***.org) and phone number. Harry works at Bill & Melinda Gates Foundation as Sr Program Officer. Harry … WebOct 21, 2024 · 2024 /PRNewswire/ -- SK bioscience Appoints New Executives towards Global Business Growth epinephrine and anaphylaxis
SK bioscience Appoints New Executives towards Global Business …
WebSep 15, 2024 · Kleanthous H 18, Sheahan TP 3, Smith KD 19, Fuller DH 8, Villinger F 7, Bloom J 4, ... 14 Roland Tisch, 15 Derek T. O’Hagan, 16 Robbert Van Der Most, 17 Wesley C. Van Voorhis, 12 Davide Corti, 18 Jason S. McLellan, 11 Harry Kleanthous, 19 Timothy P. Sheahan, 3 Kelly D. Smith, 20 Deborah H. Fuller, 9, 10 Francois Villinger, 8 Jesse … WebFeb 11, 2024 · Harry Kleanthous is an employee of the Bill and Melinda Gates Foundation. Ching-Lin Hsieh and Jason S. McLellan are inventors on U.S. patent application no. 63/032,502 Engineered Coronavirus Spike (S) Protein and Methods of Use Thereof. WebAug 8, 2024 · Pre-existing immunity to influenza is dependent on a number of factors and can vary greatly within and across influenza subtypes. In this study, volunteers (aged 18–85 years) were vaccinated with split, inactivated Fluzone TM in four consecutive influenza seasons from 2013 to 2016. The impact of repeat vaccination on breadth and durability … epinephrine and beta blocker interactions